Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.

This summary report looks at approaches like relaxation techniques, selective serotonin reuptake inhibitors (SSRIs), sleep and helpful thinking patterns as part of the different mental health treatments and approaches currently available.

Professor Catherine Harmer, study author, Department of Psychiatry, University of Oxford, said:

 

'Clinical trials show that SSRIs (antidepressants) can help treat anxiety and depression in young people, but they aren’t a solution for everyone. We need to start again when it comes to developing new treatments for young people and we need more research on how treatments work in this age group and how we can make them work better.' 

This publication is released alongside Insights from the Wellcome Global Monitor, a new global survey looking into people's experiences and views on mental health and science. The Global Monitor report highlights that over nine in ten people worldwide (92%) feel mental health is as or more important than physical health for overall wellbeing, with almost half (46%) saying it is more important.

Despite the high value people put on mental health, the survey found that science’s role in understanding and alleviating mental health issues seems unclear to many. Less than a third said science can explain a lot about how feelings and emotions work (27%) or can do a lot to help treat anxiety or depression (31%). In contrast, about half said science can do a lot to help treat infectious diseases (53%) or cancer (49%).  

Professor Miranda Wolpert, Director of Mental Health at Wellcome, said: 

 

'It’s clear that people around the world really value mental health but they don’t see science’s role in improving it. This is perhaps not that surprising, when we still know so little about what works for whom, and why. Science has enormous potential to improve mental health and researchers across the world are working to deepen our understanding and develop new treatment approaches. It might not be easy, but it’s within our grasp. Now is the time to go further and faster to find solutions to the problems faced by all of us.'

Read the full news story and the Wellcome Global Monitor Mental Health report

 

Similar stories

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.